STRATA Skin Sciences Inc(SSKN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 4:00 PM ET (Korea 10/24 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.62 | Insider Own | 33.28% | Shs Outstand | 5.3M | Perf Week | -84.18% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 28.33% | Insider Trans | -0.46% | Shs Float | 3.9M | Perf Month | -85.17% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.26 | Inst Own | 19.32% | Short Float | 9.13% | Perf Quarter | -87% |
| Income | -0.01B | P/S | 0.04 | EPS this Y | -648.25% | Inst Trans | -3.07% | Short Ratio | 0.8 | Perf Half Y | -89.63% |
| Sales | 0.03B | P/B | 0.76 | EPS next 5Y | - | ROA | -31.13% | Short Interest | 0.36M | Perf YTD | -84.94% |
| Book/sh | 0.25 | P/C | 0.16 | EPS past 3/5Y | -49.38% -17.46% | ROE | -207.19% | 52W High | -95.08% ($3.86) | Perf Year | -92.85% |
| Cash/sh | 1.2 | P/FCF | - | Sales past 3/5Y | 3.84% 1.22% | ROIC | -71.29% | 52W Low | 5.44% ($0.18) | Perf 3Y | -98.31% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -0.81% | Gross Margin | 57.76% | Volatility(W/M) | 31.96% 14.28% | Perf 5Y | -99.2% |
| Dividend TTM | - | EV/Sales | 0.33 | Sales Y/Y TTM | -5.19% | Oper. Margin | -20.86% | ATR (14) | 0.15 | Perf 10Y | -99.62% |
| Dividend Ex-Date | - | Quick Ratio | 0.75 | EPS Q/Q | 31.1% | Profit Margin | -35.64% | RSI (14) | 17.79 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.95 | Sales Q/Q | -21.23% | SMA20 | -81.5% ($1.03) | Beta | 0.48 | Target Price | $10.8 |
| Payout | - | Debt/Eq | 12.45 | Earnings | 2025/11/13 | SMA50 | -84.21% ($1.2) | Rel Volume | 0 | Prev Close | $0.19 |
| Employees | 106 | LT Debt/Eq | 10.82 | EPS/Sales Surpr. | 100.79% -10.21% | SMA200 | -89.51% ($1.81) | Avg Volume(3M) | 0.45M | Price | $0.19 |
| IPO | 2005/10/28 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
🏥 STRATA Skin Sciences (SSKN) is a company specializing in aesthetic and dermatologic medical equipment that develops Xtrac excimer laser devices for the precision treatment of chronic skin conditions such as psoriasis, vitiligo, and acne, and operates a unique partnership model with a per-treatment fee structure.
Over the past 1 year, on the lower side
95% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
SSKN has weak earning power
Of every $100 in sales, $20.86 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -648.3% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $4. Peers typically go for $204.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.2%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 19.3%.
Tap to view numbers
It ranks #142 of 144 in the industry
Based on market cap of $1M.
NXL#140 Nexalin Technology Inc $2M PER - 
NUWE#141 Nuwellis Inc $1M PER - SSKN#142 STRATA Skin Sciences Inc $1M PER - 
GCTK#142 GlucoTrack Inc $1M PER - 
PFSA#143 Profusa Inc $1M PER - 
FAQ
What kind of company is SSKN?
SSKN belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SSKN?
The market cap of SSKN is approximately $1M, ranking 5,852 within its sector.
What is the 52-week high and low for SSKN?
SSKN has recorded a 52-week high of $3.86 and a low of $0.18.
